Heart Failure NYHA Class III: Clinical Trials

52 trials for Heart Failure NYHA Class III, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

17 completed, 13 recruiting, 8 unknown, 5 active not recruiting. 29 Not applicable, 4 Phase 1, 4 Phase 2, 2 Phase 3, 2 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable29Completed 10, Recruiting 10, Unknown 4, Active not recruiting 3, Not yet recruiting 2
Phase 14Enrolling by invitation 1, Not yet recruiting 1, Recruiting 1, Unknown 1
Phase 24Not yet recruiting 1, Recruiting 1, Unknown 1, Withdrawn 1
Phase 32Completed 1, Recruiting 1
Phase 42Unknown 2

Follow Heart Failure NYHA Class III: new trials by email Literature Review of Heart Failure NYHA Class III trials Research Report on Heart Failure NYHA Class III

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Barostim-Enabled NEurohormonal Intervention For Improving Treatment of Heart Failure
Barostim System, Usual care medical management - Heart Failure, Heart Failure NYHA Class II
Not applicableRecruitingCVRx, Inc.25002026-04-242026-10-21
Heart Failure Management for Patient With CIED Remotely Monitored
SmartSignalHF, HF RM standard of care - Heart Failure, Heart Failure NYHA Class II
Not applicableRecruitingImplicity11322025-12-192026-03-31
Narrative Intervention for Chronic Illness- Heart Failure Trial (NICI-HF)
Narrative Intervention for Chronic Illness-Heart Failure, Attention Control - Heart Failure, Heart Failure NYHA Class III
Phase 1 / Phase 2Not yet recruitingUniversity of Colorado, Denver3002025-09-012024-11-13
REDUCED FUNCTIONALITY AND KINESIOPHOBIA IN PATIENTS WITH HEART FAILURE: USE OF ALTERNATIVE THERAPEUTIC STRATEGIES
Low Frequency Neuromuscular Electrical Stimulation, Medium Frequency Neuromuscular Electrical Stimulation, Neuromuscular Electrical Stimulation without generating contractility - Heart Failure, Heart Failure NYHA Class III
Not applicableNot yet recruitingUniversidade Federal do Rio Grande do Norte542025-08-182025-08-01
Association Between the Sit-To-Stand Test and the Prognosis of Patients With Heart Failure
1-minute sit-to-stand test - Heart Failure, Heart Failure NYHA Class IV
Active not recruitingCentro Universitário Augusto Motta682025-07-162026-07-14
Optimization of STAR
STAR condition 1, STAR condition 2, STAR condition 3 - Heart Failure NYHA Class II, Heart Failure NYHA Class III
Not applicableNot yet recruitingUMC Utrecht3202025-07-012025-07-15
An Early Feasibility Study Evaluation of an Implant Free Interatrial Shunt to Improve Heart Failure
PAS-C System - Heart Failure, Heart Failure NYHA Class III
Not applicableActive not recruitingInterShunt Technologies, Inc.202025-05-152026-05-27
Whole Heart Radiotherapy for End-stage Heart Failure
Whole Heart Radiation Therapy - Heart Failure NYHA Class III, Heart Failure NYHA Class IV
Phase 1Enrolling by invitationMcGill University Health Centre/Research Institute of the McGill University Health Centre62025-04-302025-05-14
Sustaining Home Heart Failure Palliative Care in Rural Appalachia
HF-FamPALhomeCARE - Heart Failure NYHA Class III, Heart Failure NYHA Class IV
Not applicableRecruitingWest Virginia University2082025-04-012026-03-09
Real World Effectiveness of the Cordella Pulmonary Artery Sensor System in Patients With Chronic Heart Heart Failure
Cordella PA Sensor System, Standard of Care Pharmacologic Therapy - Heart Failure NYHA Class III, Heart Failure
RecruitingEndotronix, Inc.21502025-02-072025-11-19
Optimizing HFrEF Patients Using BaroStim and CardioMems
BaroStim - Heart Failure NYHA Class III
Phase 2 / Phase 3RecruitingNorthwell Health152025-01-172026-02-10
Atrial Appendage Micrograft Transplants to Assist Heart Repair After Cardiac Surgery
Epicardial AAMs-patch transplantation, RNA-stabilized whole blood sampling, Plasma sampling - Ischemic Heart Disease, Ischemic Cardiomyopathy
Not applicableRecruitingHospital District of Helsinki and Uusimaa502024-04-012024-04-19
Comprehensive Hybrid Cardiac Rehabilitation Trial on Heart Failure
Comprehensive Initial Assessment, Continuous evaluation, Interval Exercise - Heart Failure NYHA Class II, Heart Failure NYHA Class III
Not applicableRecruitingUniversidad de La Frontera1522024-04-012024-12-03
Beneficial Effects of Vitamin D Combined With Oral Iron Supplementation in Patients With Chronic Heart Failure and Iron Deficiency
Sucrosomial iron, Vitamin D, Ferric Carboxymaltose 50 MG/ML - Heart Failure, Iron-deficiency
Phase 4UnknownUniversity of Padova2582024-01-152023-12-15
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
Cordella™ Pulmonary Artery Sensor System - Heart Failure NYHA Class II, Heart Failure NYHA Class III
Not applicableRecruitingEndotronix, Inc.17502023-11-292026-06-29
Gender-Based Differences in Heart Failure Hospitalizations Among Patients With Heart Failure Treated With Spironolactone
Spironolactone - Heart Failure, Heart Failure With Reduced Ejection Fraction
CompletedAhmad Abdullah Salawi5092023-10-012025-03-24
A Study to Improve Physician-Youth Communication and Medical Decision Making
We Chatt communication tool, Usual/standard care - Heart Failure NYHA Class II, Heart Failure NYHA Class III
Not applicableCompletedUniversity of Michigan622023-09-142025-06-18
Early Metabolic Adaptations to SGLT2 Inhibition in Heart Failure
Heart Failure NYHA Class II, Heart Failure NYHA Class III
Active not recruitingUniversity of Pennsylvania402023-06-272026-06-04
Yoga Based Cardiac Rehabilitation in Heart Failure Failure
Yoga-CaRe HF, Health Education - Heart Failure With Reduced Ejection Fraction, Heart Failure NYHA Class II
Not applicableRecruitingCentre for Chronic Disease Control, India35002023-04-242026-09-14
Autologous Induced Pluripotent Stem Cells of Cardiac Lineage for Congenital Heart Disease
iPSC-CL - Univentricular Heart, Congenital Heart Disease
Phase 1RecruitingHeartWorks, Inc.502023-02-032026-03-13

Showing 20 of 52. Sign in to see all of them.

Narrower conditions

Heart Failure (36)  ·  Heart Diseases (6)  ·  Cardiovascular Diseases (5)  ·  Motor Activity (5)  ·  Heart Failure, Systolic (3)  ·  Coitus (2)  ·  Amyloid Neuropathies, Familial (1)  ·  Anemia, Iron-Deficiency (1)  ·  Bundle-Branch Block (1)  ·  Coronary Artery Disease (1)  ·  Diabetes Mellitus (1)  ·  Dyspnea (1)  ·  Heart Defects, Congenital (1)  ·  Heart Failure, Diastolic (1)  ·  Hypertrophy, Left Ventricular (1)

Broader conditions

Cardiovascular Diseases (35)  ·  Heart Diseases (34)  ·  Behavior (7)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  Metabolic Diseases (3)  ·  Nutritional and Metabolic Diseases (3)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Hemic and Lymphatic Diseases (2)  ·  Pathologic Processes (2)  ·  Sexual Behavior (2)  ·  Vascular Diseases (2)  ·  Amyloid Neuropathies (1)  ·  Amyloidosis (1)  ·  Amyloidosis, Familial (1)  ·  Anemia (1)

Interventions

Activities of Daily Living (1)  ·  BID protein, human (1)  ·  Blood Specimen Collection (1)  ·  Drug Therapy (1)  ·  Echocardiography (1)  ·  Echocardiography, Transesophageal (1)  ·  Enalapril (1)  ·  Exercise (1)  ·  Furosemide (1)  ·  Psychiatric Rehabilitation (1)  ·  Resistance Training (1)  ·  Saline Solution (1)  ·  Sodium Channel Blockers (1)  ·  Sodium Potassium Chloride Symporter Inhibitors (1)  ·  Spironolactone (1)

Sponsors

Endotronix, Inc. (6)  ·  Abbott Medical Devices (2)  ·  Medtronic Cardiac Rhythm and Heart Failure (2)  ·  West Virginia University (2)  ·  Aalborg University (1)  ·  Ahmad Abdullah Salawi (1)  ·  Alexandria University (1)  ·  BackBeat Medical Inc (1)  ·  Biosistemak Institute for Health Systems Research (1)  ·  Boston Scientific Corporation (1)  ·  CVRx, Inc. (1)  ·  Celestino Sardu (1)  ·  Central Hospital, Nancy, France (1)  ·  Centre for Chronic Disease Control, India (1)  ·  Centro Universitário Augusto Motta (1)

Countries

United States (25)  ·  Belgium (5)  ·  Ireland (4)  ·  Denmark (3)  ·  Germany (3)  ·  Brazil (2)  ·  Canada (2)  ·  China (2)  ·  France (2)  ·  Brunei (1)  ·  Chile (1)  ·  Egypt (1)  ·  Finland (1)  ·  Greece (1)  ·  Hong Kong (1)

Top investigators

Edward Karst (3)  ·  Andrea Sauerland (2)  ·  Birthe Dinesen, PhD (1)  ·  Christopher M Celano, MD (1)  ·  Dorairaj Prabhakaran, MD DM (Cardiology) (1)  ·  Elisabeth L Sattler, PhD, BSPharm (1)  ·  Emma Birks, MD (1)  ·  Esteban de Manuel (1)  ·  Federico Capone, MD (1)  ·  Gaetano Marrone (1)  ·  Heleen Westland, PhD (1)  ·  Ian J Gerard, MD, PhD (1)  ·  Jamie Pelzel, MD (1)  ·  Javed Butler, MD (1)

Results publications

PMID 28599667, PMID 29490680, PMID 30972619, PMID 31256261, PMID 31538944, PMID 32264715, PMID 33100036, PMID 34255642, PMID 34386535, PMID 34461042, PMID 34763080, PMID 35266003, PMID 35928510, PMID 36456066, PMID 36894879, PMID 36920122, PMID 37286262, PMID 37943225, PMID 39097733, PMID 39152983, PMID 39392161, PMID 39480670, PMID 39610971, PMID 40055735, PMID 40223608, PMID 41485016, PMID 41686133, PMID 42168470, PMID 42201276, PMID 42201288, PMID 42206402, PMID 42662629

NIH funding

K23HL145096 (1), R01NR021630 (1), R15NR018547 (1)